期刊文献+

IL-22在类风湿关节炎中的表达及临床意义 被引量:11

Expression and clinical significance of interleukin-22 in patients with rheumatoid arthritis
下载PDF
导出
摘要 目的:探讨RA患者IL-22的表达水平并分析其临床意义。方法:流式细胞术检测RA患者(50例)、OA患者(15例)、健康对照组(15例)外周血及RA关节滑液Th22细胞所占比例,ELISA法检测血清及RA关节滑液中IL-22水平。检测RA患者疾病活动性、临床指标、骨破坏情况,分析其与IL-22水平相关性。两组间比较用t检验,相关性分析采用Pearson直线相关分析法,多组样本比较用Kruskal-Wallis H检验。结果:RA患者外周血中Th22细胞比例高于OA组(t=2.290,P=0.021)及健康对照组(t=2.524,P=0.015);RA患者血清IL-22水平高于OA患者(t=2.560,P=0.014)及健康对照组(t=2.768,P=0.009)。RF阳性RA血清IL-22水平高于RF阴性RA(t=2.322,P=0.035)。抗CCP抗体阳性RA血清IL-22水平高于抗CCP抗体阴性RA(t=2.504,P=0.015)。RA血清IL-22水平与ESR、RF、DAS28评分呈正相关关系(r分别为0.312、0.314、0.332,P<0.05)。RA患者血清IL-22水平随骨侵蚀的加重呈递增趋势,X线不同分期之间差异有统计学意义(H=9.14,χ_(0.05(3))~2=7.81,H>χ_(0.05(3))~2,P<0.05)。有关节积液RA患者血清IL-22水平高于无关节积液RA患者(t=2.587,P=0.012),关节滑液IL-22水平高于血清(t=2.668,P=0.011),与关节滑液Th22细胞比例无相关性(r=0.287,P=0.065)。结论:RA患者血清及关节滑液IL-22水平增高,与疾病活动性及骨破坏相关,可成为病情评估与骨破坏的指标。IL-22可能为RA治疗的新靶点。 Objective: To explore the expression of IL-22 in the patients with rheumatoid arthritis,and to define the clinical significance of IL-22 cells for RA. Methods: A total of 50 RA patients,15 OA patients and 15 healthy controls were enrolled. The proportion of Th22 cells in peripheral blood and synovial fluid( SF) of RA patients was detected by flow cytometry; the levels of IL-22 in serum and synovial fluid of RA patients were detected by ELISA. The clinical parameters of disease activity were assessed including ESR,RF,CRP,DAS28,anti CCP and the degree of bone erosions determined by X-rays. Pearson correlation analysis,t test and Kruskal-Wallis H test were used for statistical analysis. Results: The proportion of Th22 cells in RA patients was higher than that of OA patients( t= 2. 290,P = 0. 021) and healthy controls( t = 2. 524,P = 0. 015). IL-22 levels in RA patients were higher than that of OA patients( t = 2. 560,P = 0. 014) and healthy controls( t = 2. 768,P = 0. 009). IL-22 in the RF positive group were higher than that of RF negative group( t = 2. 322,P = 0. 035). IL-22 in the anti-CCP antibody positive group were higher than that of anti-CCP antibody negative group( t = 2. 504,P = 0. 015). The levels of IL-22 were correlated positively with ESR,RF,DAS28( r = 0. 312,0. 314,0. 332,P〈0. 05). The levels of IL-22 were increased gradually along with the aggravation of bone erosions. There were statistical significant difference among different X-ray stagings( H = 9. 14,χ_(0.05(3))~2= 7. 81,H χ_(0.05(3))~2,P〈0. 05). Serum IL-22 levels in the RA patients with joint effusion were higher than that of without( t = 2. 587,P = 0. 012). The levels of IL-22 in SF were higher than that in serum( t =2. 668,P = 0. 011),and had no correlation with the proportion of Th22 cells in SF. Conclusion: The expression of IL-22 in serum and joint effusion of RA patients increase. The level of IL-22 may be useful marker for assessment of disease activity and finding of bone erosions. Therapeutic targeting of IL-22 may be valuable for the intervention of RA.
作者 邵勤 高洪燕 周小莉 曹春辉 SHAO Qin GAO Hong-Yan ZHOU Xiao-Li CAO Chun-Hui.(Department of Rheumatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2017年第1期103-107,共5页 Chinese Journal of Immunology
基金 重庆市卫计委医学科研项目(2015MSXM080)
关键词 关节炎 类风湿 白细胞介素22 疾病活动性 骨侵蚀 Arthritis rheumatoid Interleukin-22 Disease activity Bone erosion
  • 相关文献

参考文献1

二级参考文献14

  • 1Azizi G,Jadidi-Niaragh F,Mirshafiey A.Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis[J]. Int J Rheum Dis,2013,16 (3):243-253.
  • 2Dong W,Zhu P.Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis:replication to clinical therapeutics.Autoimmun Rev,2012,11(12):844-851.
  • 3Yang X,Zheng SG.Interleukin-22: A likely target for treatment of autoimmune diseases.Autoimmun Rev,2014,13(6):615-620.
  • 4Zhao L,Jiang Z,Jiang Y,et al.IL-22+ CD4+ T cells in patients with rheumatoid arthritis.Int J Rheum Dis,2013,16(5):518- 526.
  • 5Pan HF,Li XP,Zheng SG,et al.Emerging role of interleukin-22 in autoimmune diseases.Cytokine Growth Factor Key,2013,24(1):51- 57.
  • 6McGeachy MJ,Bak-Jensen KS,Chen Y,et al.TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 features of human Th17 cellsLl].Exp Med,2007,204(8):1849-1861.
  • 7Cooles FA,Isaacs JD.Pathophysiology of rheumatoid arthritis[J].Curr Opin Rheumatol,2011,23(3):233-240.
  • 8Aujla SJ,KoUs JK.IL-22:a critical mediator in mucosal host defense[J].J Mol Med (Berl),2009,87(5):451-454.
  • 9Kreymborg K,Etzensperger G,Dumoutier T,et al.IL-22 is expressed by Th17 cells in an IL-23-dependent fashion,but not required for the development of autoimmune encephalomyelitis [J] .J Immunol,2007,179(12):8098-8104.
  • 10Ikeuchih H,Kuroiwa T,Hiramatsu N,et al.Expression of interleukin-22 in rheumatoid arthritis:potential role as a proinflammatory cytokine[J].Arthritis and Rheumatism, 2005,52 (4): 1037 - 1046.

共引文献3

同被引文献113

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部